ArticleCardiovascular diabetology2025

Empagliflozin-induced lipidome remodeling in type 2 diabetes: mechanistic insights and translational perspectives.

Carmine Izzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.